{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:49:03Z","timestamp":1790732943452,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI129540"],"award-info":[{"award-number":["AI129540"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI145813"],"award-info":[{"award-number":["AI145813"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI148304"],"award-info":[{"award-number":["AI148304"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.coviro.2021.10.003","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T03:34:28Z","timestamp":1635392068000},"page":"158-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Hepatitis B virus e antigen and viral persistence"],"prefix":"10.1016","volume":"51","author":[{"given":"Kuen-Nan","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Hsiung James","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2021.10.003_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104925","article-title":"Hepatitis B virus biology and life cycle","volume":"182","author":"Tsukuda","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2021.10.003_bib0010","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1073\/pnas.83.6.1578","article-title":"Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen","volume":"83","author":"Ou","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.10.003_bib0015","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1083\/jcb.106.4.1093","article-title":"Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: after signal peptide cleavage translocation can be aborted and the product released into the cytoplasm","volume":"106","author":"Garcia","year":"1988","journal-title":"J Cell Biol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0020","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1128\/JVI.02348-08","article-title":"Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzyme","volume":"83","author":"Ito","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0025","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4049\/jimmunol.109.5.1017","article-title":"New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants","volume":"109","author":"Magnius","year":"1972","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2021.10.003_sbref0030","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1080\/21645515.2019.1607132","article-title":"Is the function of the HBeAg really unknown?","volume":"15","author":"Milich","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.coviro.2021.10.003_bib0035","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1128\/jvi.66.9.5682-5684.1992","article-title":"The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host","volume":"66","author":"Chen","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0040","doi-asserted-by":"crossref","first-page":"9652","DOI":"10.1128\/JVI.00867-09","article-title":"The size of the viral inoculum contributes to the outcome of hepatitis B virus infection","volume":"83","author":"Asabe","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.10.003_sbref0045","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.immuni.2016.04.008","article-title":"Maternal-derived hepatitis B virus e antigen alters macrophage function in offspring to drive viral persistence after vertical transmission","volume":"44","author":"Tian","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2021.10.003_bib0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jmv.20176","article-title":"Evolution of precore\/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion","volume":"74","author":"Liu","year":"2004","journal-title":"J Med Virol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0055","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0140-6736(89)90713-7","article-title":"Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection","volume":"2","author":"Carman","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2021.10.003_bib0060","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1007\/s10620-010-1179-4","article-title":"Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection","volume":"55","author":"Liaw","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.coviro.2021.10.003_bib0065","doi-asserted-by":"crossref","first-page":"14913","DOI":"10.1073\/pnas.0406282101","article-title":"A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen","volume":"101","author":"Chen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.10.003_bib0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coi.2015.06.016","article-title":"Host-virus interactions in hepatitis B virus infection","volume":"36","author":"Guidotti","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tim.2017.07.006","article-title":"Mechanisms of hepatitis B virus persistence","volume":"26","author":"Tsai","year":"2018","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.coviro.2021.10.003_sbref0080","article-title":"Immunobiology and pathogenesis of hepatitis B virus infection","author":"Iannacone","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0085","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3389\/fimmu.2020.00849","article-title":"Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches","volume":"11","author":"Fisicaro","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0090","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jhepr.2019.06.001","article-title":"HBeAg seroconversion is associated with a more effective PD-L1 blockade during chronic hepatitis B infection","volume":"1","author":"Ferrando-Martinez","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.coviro.2021.10.003_bib0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fcimb.2019.00207","article-title":"The PD-1\/PD-L1 axis and virus infections: a delicate balance","volume":"9","author":"Schonrich","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0100","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41598-020-58870-2","article-title":"Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2021.10.003_bib0105","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jhep.2019.06.028","article-title":"Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: a pilot study","volume":"71","author":"Gane","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0110","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM197604012941402","article-title":"e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants","volume":"294","author":"Okada","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2021.10.003_bib0115","first-page":"703","article-title":"CTLA4 interferes with the HBVspecific T cell immune response (Review)","volume":"42","author":"Cao","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.coviro.2021.10.003_bib0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10875-010-9483-5","article-title":"Hepatitis B e-antigen persistency is associated with the properties of HBV-specific CD8 T cells in CHB patients","volume":"31","author":"Peng","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.micpath.2019.01.026","article-title":"TIM-3 as a marker of exhaustion in CD8(+) T cells of active chronic hepatitis B patients","volume":"128","author":"Mohammadizad","year":"2019","journal-title":"Microb Pathog"},{"key":"10.1016\/j.coviro.2021.10.003_bib0130","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.3389\/fimmu.2019.02240","article-title":"Heterogeneity of HBV-specific CD8(+) T-cell failure: implications for immunotherapy","volume":"10","author":"Heim","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0135","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12703\/P6-13","article-title":"The M1 and M2 paradigm of macrophage activation: time for reassessment","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000Prime Rep"},{"key":"10.1016\/j.coviro.2021.10.003_bib0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004032","article-title":"Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages","volume":"10","author":"Bility","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.10.003_bib0150","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/cmi.2015.96","article-title":"Liver natural killer cells: subsets and roles in liver immunity","volume":"13","author":"Peng","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0155","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/hep.21060","article-title":"The liver as an immunological organ","volume":"43","author":"Racanelli","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2021.10.003_bib0160","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.4049\/jimmunol.1500846","article-title":"NK cells help induce anti-hepatitis B virus CD8+ T cell immunity in mice","volume":"196","author":"Zheng","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0165","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-020711-075005","article-title":"Controlling natural killer cell responses: integration of signals for activation and inhibition","volume":"31","author":"Long","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0170","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhep.2010.07.009","article-title":"Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B","volume":"54","author":"Tjwa","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002594","article-title":"TGF-beta1 down-regulation of NKG2D\/DAP10 and 2B4\/SAP expression on human NK cells contributes to HBV persistence","volume":"8","author":"Sun","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.10.003_sbref0180","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fcell.2020.00421","article-title":"Hepatitis B e antigen induces NKG2A(+) natural killer cell dysfunction via regulatory T cell-derived interleukin 10 in chronic hepatitis B virus infection","volume":"8","author":"Ma","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0185","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.imbio.2014.07.008","article-title":"The hepatitis B virus e antigen suppresses the respiratory burst and mobility of human monocytes and neutrophils","volume":"219","author":"Leu","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.coviro.2021.10.003_bib0190","doi-asserted-by":"crossref","first-page":"10935","DOI":"10.1111\/jcmm.15723","article-title":"Negative feedback loop of ERK\/CREB\/miR-212-3p inhibits HBeAg-induced macrophage activation","volume":"24","author":"Chen","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.coviro.2021.10.003_sbref0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007690","article-title":"Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection","volume":"15","author":"Yang","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.10.003_bib0200","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","article-title":"The many roles of FAS receptor signaling in the immune system","volume":"30","author":"Strasser","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2021.10.003_sbref0205","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.ajpath.2019.07.014","article-title":"Repression of death receptor-mediated apoptosis of hepatocytes by hepatitis B virus e antigen","volume":"189","author":"Liu","year":"2019","journal-title":"Am J Pathol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0210","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/jmv.20082","article-title":"Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus","volume":"73","author":"Song le","year":"2004","journal-title":"J Med Virol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0215","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1126\/science.7510905","article-title":"Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule","volume":"263","author":"Cheng","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.coviro.2021.10.003_bib0220","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1096\/fj.14-263822","article-title":"Hepatitis B virus core protein inhibits Fas-mediated apoptosis of hepatoma cells via regulation of mFas\/FasL and sFas expression","volume":"29","author":"Liu","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.coviro.2021.10.003_bib0225","doi-asserted-by":"crossref","first-page":"8328","DOI":"10.1074\/jbc.M006026200","article-title":"X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK\/JNK pathway","volume":"276","author":"Diao","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2021.10.003_bib0230","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01273-18","article-title":"Hepatitis B spliced protein (HBSP) suppresses Fas-mediated hepatocyte apoptosis via activation of PI3K\/Akt signaling","volume":"92","author":"Wu","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0235","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/hep.21482","article-title":"Regulation of toll-like receptor-2 expression in chronic hepatitis B by the precore protein","volume":"45","author":"Visvanathan","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2021.10.003_bib0240","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/jvh.12477","article-title":"Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients","volume":"23","author":"Visvanathan","year":"2016","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.coviro.2021.10.003_bib0245","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/hep.31112","article-title":"Hepatitis B virus particles activate toll-like receptor 2 signaling initially upon infection of primary human hepatocytes","volume":"72","author":"Zhang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2021.10.003_bib0250","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jhep.2010.12.042","article-title":"The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway","volume":"55","author":"Lang","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2021.10.003_sbref0255","article-title":"Hepatitis B e antigen inhibits NF-kappaB activity by interrupting K63-linked ubiquitination of NEMO","volume":"93","author":"Wang","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0260","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrm3644","article-title":"Molecular control of the NEMO family of ubiquitin-binding proteins","volume":"14","author":"Clark","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0265","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fimmu.2017.00029","article-title":"Canonical and non-canonical aspects of JAK-STAT signaling: lessons from interferons for cytokine responses","volume":"8","author":"Majoros","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2021.10.003_bib0270","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1038\/s41598-017-01773-6","article-title":"Hepatitis B virus e antigen activates the suppressor of cytokine signaling 2 to repress interferon action","volume":"7","author":"Yu","year":"2017","journal-title":"Sci Rep"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625721001255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625721001255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:05:14Z","timestamp":1761818714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625721001255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":54,"alternative-id":["S1879625721001255"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2021.10.003","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B virus e antigen and viral persistence","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2021.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}